Telomeres are essential for cell survival and have been implicated in the mitotic control. The telomeric protein Pin2/TRF1 controls telomere elongation and its expression is tightly regulated during cell cycle. We previously reported that overexpression of Pin2/TRF1 aects mitotic progression. However, the role of Pin2/TRF1 at the interface between cell division and cell survival remains to be determined. Here we show that overexpression of Pin2 induced apoptosis in cells containing short telomeres, but not in cells with long telomeres. Furthermore, before entering apoptosis, Pin2-expressing cells ®rst accumulated in mitosis and strongly stained with the mitosis-speci®c MPM2 antibody. Moreover, Pin2-induced apoptosis is potentiated by arresting cells in mitosis, but suppressed by accumulating cells in G1. In addition, overexpression of Pin2 also resulted in activation of caspase-3, and its proapoptotic activity was signi®cantly reduced by inhibition of caspase-3. These results indicate that up-regulation of Pin2/TRF1 can speci®cally induce entry into mitosis and apoptosis, likely via a mechanism related to activation of caspase-3. Signi®cantly, we also found that, out of 51 human breast cancer tissues and 10 normal controls examined, protein levels of Pin2/TRF1 in tumors were signi®cantly lower than in normal tissues, as detected by immunoblotting analysis and immunocytochemistry. Since down-regulation of Pin2/TRF1 allows cells to maintain long telomeres, these results suggest that down-regulation of Pin2/TRF1 may be important for cancer cells to extend their proliferative potential. Oncogene (2001) 20, 1497 ± 1508.
Introduction
Telomeres are essential for preserving chromosome integrity during cell division. Telomeres are composed of repetitive DNA sequences of TTAGGG arrays concealed by a complex of telomeric proteins that protects the ends from exonucleolytic attack, fusion and incomplete replication (Greider and Blackburn, 1996; Lundblad, 2000; Zakian, 1995) . There is growing evidence suggesting that both the shielding of telomeric ends and their elongation are dependent on telomerebinding proteins. For example, homeostasis of telomere length in budding and ®ssion yeast cells requires the telomeric proteins Rap1p and Taz1, respectively (Cooper et al., 1997; Krauskopf and Blackburn, 1996; Marcand et al., 1997) . Mutagenesis analyses of telomeric sequences of Kluyveromyces lactis also suggest that telomere length is modulated by proteins that bind to double strand telomeric DNA (McEachern and Blackburn, 1995) . Telomere maintenance in mammalian cells is also regulated by telomere binding proteins, including TRF1 and TRF2 (Chong et al., 1995; van Steensel and de Lange, 1997) . TRF1 has been shown to negatively regulate telomere maintenance; overexpression of TRF1 accelerates telomere shortening, whereas dominant-negative TRF1 increases telomere elongation (van Steensel and de Lange, 1997) . These results indicate that telomere-binding proteins play a pivotal role in telomere metabolism.
Several observations link telomeres to mitotic progression. In Drosophila, deletion of telomeres triggers mitotic arrest and apoptosis (Ahmad and Golic, 1999) . In ®ssion yeast, telomeres are clustered at the nuclear periphery in G2, but this association is disrupted in mitosis (Funabiki et al., 1993) , and telomeres have been shown to mediate the attachment of chromosomes to spindle bodies and lead chromosome movement in meiotic prophase (Chikashige et al., 1994) . In budding yeast, elimination of telomeres causes a Rad9p-mediated cell cycle arrest in G2 in budding yeast (Sandell and Zakian, 1993) and mutations in the related TEL1 and MEC1 genes result in shortened telomeres, G2/M checkpoint defect and genomic instability (Greenwell et al., 1995; Sanchez et al., 1996) . Similarly, mutations in its human counterpart, the ATM gene, causes ataxia-telangiectasia (AT) both in humans and mice, displaying a wide range of abnormalities, including those related to telomere dysfunction (Barlow et al., 1996; Elson et al., 1996; Savitsky et al., 1995; . More interestingly, cell lines derived from AT patients have shortened telomere lengths (Metcalfe et al., 1996; Pandita et al., 1995; Xia et al., 1996) and defected G2/M checkpoint (Beamish et al., 1994; Rudolph and Latt, 1989) . Finally, mutations in the Tetrahymena telomeric DNA sequence has been shown to cause a block in anaphase chromosome separation (Kirk et al., 1997) . Collectively, these results suggest that telomeres may be important for regulation of mitosis. However, little is known about the identity and function of the signaling molecule(s) involved in this process.
We independently isolated the telomere-binding protein Pin2 as a one of three proteins, Pin1 ± 3, which interact with NIMA kinase that is an essential mitotic kinase in Aspergillus nidulans (Lu et al., 1996) . Characterization of these Pin proteins shows that they are all involved in mitotic regulation (Lu, 2000) . Pin1 binds and regulates the function of a subset of phosphoproteins by controlling the conformation of speci®c phosphorylated Ser/Thr-Pro motifs (Lu et al., 1999a,b; Shen et al., 1998; Yae et al., 1997; Zhou et al., 2000) . Pin2 is identical in the sequence to TRF1 apart from an internal deletion of 20 amino acids . TRF1 and Pin2 are likely two alternatively spliced isoforms of the same gene PIN2/ TRF1, as suggested by Young et al. (1997) . For clarity, we will here use Pin2 for the 20 amino acid deletion isoform and TRF1 for the 20 amino acid containing isoform, as they were originally identi®ed (Chong et al., 1995; Shen et al. 1997) , and will refer to the endogenous Pin2 and TRF1 proteins as Pin2/TRF1 since it is dicult to physically or functionally separate these isoforms at the present time. However, we have shown that Pin2 is 5 ± 10-fold more abundant than TRF1 in the cells and the expression level of Pin2/ TRF1 is tightly regulated during the cell cycle . Both Pin2 and TRF1 contain a D-like motif similar to the destruction box present in many mitotic proteins, and their protein levels are signi®cantly increased in late G2 and mitosis and then degraded as cells exit from mitosis. Furthermore, overexpression of Pin2 or TRF1 resulted in accumulation of the cells in G2 or M phase of the cell cycle . Although these results together suggest that Pin2/ TRF1 may aect mitotic progression, it is not clear whether Pin2/TRF1 has any speci®c eect on mitosis. Furthermore, it is unknown why overexpression of Pin2/TRF1 has no eect on the cell cycle in some cells (van Steensel and de Lange, 1997) .
Here, we describe that overexpression of Pin2 induced entry into mitosis and apoptosis only in cells with short telomeres, but not in cells with long telomeres. Moreover, Pin2-induced apoptosis is potentiated by mitotic arrest, but not suppressed by G1 arrest. Importantly, Pin2 overexpression induced activation of caspase-3, a key executioner of apoptosis, and its ability to induce apoptosis was signi®cantly suppressed by inhibition of caspase-3. These results have demonstrated that Pin2/TRF1 can speci®cally aect the cell cycle, triggering mitotic entry and apoptosis in the cells containing short telomeres. Consistent with a potential role of Pin2/TRF1 in regulation of cell survival, we found that protein levels of Pin2/TRF1 were signi®cantly reduced in human breast cancer tissues, as compared with those in normal controls. Since down-regulation of Pin2/TRF1 allows cells to maintain long telomeres (van Steensel and de Lange, 1997) , these results suggest that down-regulation of Pin2/TRF1 may be important for cancer cells to divide continuously.
Results

Overexpression of Pin2 induces apoptosis in HeLa cells
We previously showed that ectopic expression of Pin2 or TRF1 in HeLa cells caused accumulation of cells with 4N DNA content , which is normally observed in G2 and/or M phase of the cell cycle. To further characterize this Pin2/TRF1-induced phenotype, we transfected cDNA constructs for Pin2 and TRF1 into HeLa cells and A-T22IJE-T. A-T22IJE-T cells were originally derived from primary A-T ®broblasts and contain no ATM protein (Ziv et al., 1989) . After transient expression, two proteins were detected in the nucleus of cells 8 h after transfection by indirect immuno¯uorescence. However, cells expressing Pin2 or TRF1 rounded up and died after 28 ± 32 h, and a few cells were detectable at 72 h, suggesting that Pin2 and TRF1 were toxic to the cells. To visualize surviving Pin2/TRF1-expressing cells, we co-transfected cells with a b-gal expression construct. After co-transfection of HeLa or A-T22IJE-T cells with Pin2 or TRF1 and b-gal constructs, the number of X-galstained surviving blue cells was signi®cantly reduced, as compared with that of empty vector-or antisense Pin2-transfected cells (Figure 1 , data not shown). Since there was no detectable dierence in phenotypic changes induced by Pin2 or TRF1 (Table 1) , we focused on Pin2 for subsequent experiments.
The morphological changes of Pin2-expressing cells were suggestive of apoptosis. To con®rm that overexpression of Pin2 indeed induces apoptosis, we ®rst used the TUNEL assay, which detects apoptosisspeci®c DNA breaks (Douglas et al., 1998; Gavrieli et al., 1992) . To detect transfected cells by¯ow cytometry, HeLa cells were co-transfected with CD20, as described (Zhu et al., 1993) . Whereas there were less than 0.4 ± 1.0% TUNEL-positive cells in vectortransfected cells, about 15 ± 20% of TUNEL-positive cells were detected in a Pin2-transfected cell population (data not shown). To directly observe morphological changes of Pin2-expressing cells, we inserted green uorescence protein (GFP) at the NH 2 -terminal end of the Pin2 cDNA. After 28 h transfection, 38% of GFPPin2-expressing HeLa cells and 56% of GFP-Pin2-expressing A-T22IJE-T rounded up and the condensed chromatin became fragmented, with the formation of micronuclei (Figure 2a , also see 4a), which are characteristic of apoptotic cells. When Pin2-transfected cells were subjected to¯ow cytometry after staining with propidium iodide, as shown later in Figure 5b , about 25% of GFP-Pin2-expressing HeLa cells contained a sub-G1 DNA content, which is another feature of apoptosis. These multiple assays con®rmed that ectopic expression of Pin2 can induce apoptosis in HeLa and A-T22IJE-T cells.
The ability of Pin2 to induce apoptosis depends on the concentration of unbound Pin2 and telomere length in the cell After establishing that Pin2/TRF1 induces apoptosis, we examined its relationship to telomeres. Since the Cterminal Myb-type DNA-binding domain of Pin2/ TRF1 binds telomeric DNA repeats and is also required for Pin2/TRF1 to inhibit telomere elongation and to aect mitotic progression van Steensel and de Lange, 1997) , we examined whether this domain is required for Pin2 to induce apoptosis. Although two C-terminal truncation mutants, Pin2 1 ± 372 and Pin2 1 ± 316 were expressed in cells at levels that were similar to that of wild-type protein, they were not localized at telomeres (Figure 2 ), as shown previously van Steensel and de Lange, 1997) . In contrast to wild-type Pin2, neither of the truncation mutants induced apoptosis in HeLa (data not shown) or A-T22IJE-T cells and less than 10% of transfected cells were apoptotic (Figure 2a ± c) . These results indicate that the full-length Pin2, including telomeric DNA-binding domain is required for apoptosis induction. To further examine whether the ability of Pin2 to induce apoptosis depends on the actual binding of the full-length Pin2 to the telomeric DNA, we introduced triple Ala substitutions into three residues in Pin2, Lys401, Asp402 and Arg403. These three residues are highly conserved in Myb-type DNA-binding domains of telomeric proteins and are also involved in binding telomeric DNA, as revealed by determining the crystal structure of the DNA-binding domain of yeast RAP1 in complex with telomeric DNA (Konig et al., 1996) . When the triple Pin2 mutant (Pin2 3A ) expression construct was transfected into HeLa cells, the mutant protein was detected in the nucleus, but not at telomeres (Table 1) , as expected. However, Pin2
3A still induced apoptosis (Table 1) . These results indicate that apoptosis is induced by the full-length Pin2 protein, but its telomeric binding is not required, suggesting that apoptosis is likely due to a high concentration of unbound Pin2.
Since apoptosis induced by inhibition of telomerase depends on telomere length (Hahn et al., 1999; Herbert et al., 1999; Zhang et al., 1999) , we asked whether telomere length aected the ability of Pin2 to induce apoptosis. To address this question, we compared the ability of Pin2 to induce apoptosis in six cell lines with dierent telomere lengths, including HeLa1.2.11, which is derived from HeLa cells. In contrast to most HeLa cells that contain short telomeres (1 ± 3 kb), HeLa1.2.11 cells have rather long telomeres (15 ± 30 kb) (Table 1) (Ishibashi and Lippard, 1998) . Interestingly, Pin2 potently induced the apoptotic phenotype in three dierent cell lines, HeLa, A-T22IJE-T and A431, all of which contain short telomeres ( Figure 3a , Table 2 ) (Metcalfe et al., 1996; Pandita et al., 1995; Xia et al., 1996; Zhang et al., 1999) . In contrast, Pin2 almost completely failed to induce signi®cant apoptosis in three other cell lines, HeLa1.2.11 and 293 and HT1080, which contain long telomeres (Table 2) (Ishibashi and Lippard, 1998; van Steensel and de Lange, 1997; Zhang et al., 1999) . For example, in HeLa1.2.11 cells, expressed GFP-Pin2 was highly concentrated at telomeres, displaying a very prominent speckled pattern without aecting cell viability (Figure 3b ), which is consistent with the fact that these cells have long telomeres (Ishibashi and Lippard, 1998) . These results show that the ability of Pin2 to induce apoptosis at least in part depends on Table 1 Induction of apoptosis by Pin2 and its mutants Expression constructs expressing GFP-Pin2 or TRF1 or its various mutants were transfected into HeLa cells. Cells were ®xed at 28 h after transfection, and stained with DAPI, followed by determining percentage of cells displaying apoptotic phenotype in at least 300 GFP-positive cells. The results represent the mean+s.d. of at least three experiments. The telomeric binding of TRF1, Pin2 and its truncation mutants was reported previously and the same method was used to determine the telomeric binding of Pin2
3A
. NH 2 -terminal GFP box, GFP epitope tag inserted at the NH2-terminus; DB, the Myb-type DNA-binding domain that binds the telomeric DNA repeats; NLS, nuclear localization signal; I, 20 amino acid insert unique to TRF1 telomere length. These results are also consistent with our ®ndings that the ability of Pin2 to induce apoptosis depends on the concentration of unbound Pin2.
Overexpression of Pin2 induces mitotic entry and apoptosis
To examine whether Pin2 speci®cally aects cell cycle progression before inducing apoptosis, we performed a detailed time course analysis of morphological changes of Pin2-transfected cells. At 12 ± 16 h after transfection, GFP-Pin2 was primarily localized in the nucleus with punctate speckles during interphase, and was concentrated at telomeres with some diuse staining all over the cells in the mitotic stage (Figure 4a ). These patterns of the localization were similar to those of endogenous Pin2/TRF1 van Steensel and de Lange, 1997) , indicating that GFP does not aect the localization of the Pin2 proteins. Importantly, the number of mitotic cells was signi®cantly increased in the population of GFP-Pin2-expressing cells during the period of 20 ± 24 h after transfection (Figure 4a,b) . However, these Pin2-transfected cells apparently did not progress through normal mitosis. Instead, the condensed chromatin eventually seemed to become fragmented and micronuclei were formed (Figure 4a,b) , a phenotype characteristic of apoptotic cells. These results suggest that ectopic expression of Pin2 leads to entry into mitosis, which is followed by apoptosis.
If Pin2 ®rst induces mitotic entry and then apoptosis, there are at least two predictions. First, Pin2-induced apoptotic cells would have some mitosis-speci®c markers and, second, Pin2-induced apoptosis would be increased if cells are arrested at mitosis by other approaches, but decreased if cells are not allowed to enter mitosis. To examine the ®rst prediction, we stained Pin2-transfected cells with the phospho-speci®c MPM-2 monoclonal antibody because MPM-2 speci®-cally recognizes a subset of mitosis-speci®c phosphoproteins and has been widely used as a maker for mitotic cells (Davis et al., 1983; Matsumoto-Taniura et al., 1996; Vandre et al., 1986; Westendorf et al., 1994; Yae et al., 1997) . As shown in Figure 4c , most Pin2-expressing cells were strongly stained with MPM-2 20 ± 24 h after transfection. This staining was also observed in Pin2-expressing apoptotic cells even 28 ± 32 h after transfection, although at a weaker intensity (Figure 4c ). This, however, is expected because it is impossible to maintain the high level of mitotic phosphorylation at such a stage of apoptosis. These results con®rm that Figure 3 Expression of Pin2 induces apoptosis in A431 cells, but not in HeLa1.2.11 cells. A431 (a) and HeLa1.2.11 (b) cells were transfected with a GFP-Pin2 construct or the control GFP vector for 28 h, then ®xed and stained with DAPI, followed by microscopy. Arrows point to Pin2-expressing cells. GFP alone did not induce apoptosis (data not shown) 
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Various cell lines were transfected with GFP-Pin2 expression construct or control GFP vector for 30 h and then ®xed and stained with DAPI, followed by determining percentage of cells displaying apoptotic phenotype in total GFP-positive cells.
a Telomere length in HeLa cells used was about 1 ± 3 kb, determined as described in Materials and methods (data not shown);
b Telomere length in all A ± T cell lines examined is reported to be 1 ± 4 kb (Pandita et al., 1995; Xia et al., 1996; Metcalfe et al., 1996) , although telomere length in A-T22IJE-T cell line has not been speci®cally determined; c Telomere length in A431 and 293 is reported to be 1 ± 3 and 10 ± 12 kb respectively (Zhang et al., 1999); Telomere length in HeLa1.2.11 is reported to be 15 ± 30 kb (Ishibashi and Lippard, 1998) ; e Telomere length in HT1080 is reported to be 4 ± 9 kb (van Steensel and de Lange, 1997); +, Apoptotic phenotype is easily detected in 30 ± 55% of GFP-Pin2-expressing cells; 7, Apoptotic phenotype is detected below 5 ± 12% of GFP-Pin2-expressing cells, which were similar to control GFP-expressing cells Oncogene Apoptosis induced by telomeric protein Pin2/TRF1 S Kishi et al Pin2-expressing cells are accumulated at mitosis before entering apoptosis.
To examine the second prediction, we transfected HeLa cells with GFP-Pin2 or membrane-localized control GFP (TM-GFP) for 12 h and then treated the cells with nocodazole or lovastatin, followed by analysing the cell cycle pro®les of transfected and nontransfected cells using¯ow cytometry analysis. The membrane-localized TM-GFP was used instead of GFP because regular GFP leaked out of cells after ®xing with ethanol for¯ow cytometric assay. When cells were transfected with TM-GFP, both GFPpositive and -negative cells were almost completely arrested at mitosis after nocodazole treatment. Lovastatin treatment signi®cantly increased G1 cells and reduced S phase cells, although the arrest was not complete (Figure 5a ), as shown previously (Jakobisiak et al., 1991; Keyomarsi et al., 1991) . This is likely due to the diculty in completely synchronizing HeLa cells Figure 4 Expression of Pin2 induces mitotic entry and apoptosis in HeLa cells. After transfection with GFP-Pin2 construct, HeLa cells were monitored over time and ®xed at times indicated, stained with DAPI and microscopically examined (a). The cells with interphase, mitotic or apoptotic nuclear morphology in all GFP-Pin2-expressing cells were counted (b). Cells were stained with MPM-2 antibody, followed by¯uorescence microscopy (c) Figure 5 Pin2-induced apoptosis is potentiated by arresting cells at mitosis, but suppressed by arresting cells in G1. HeLa cells were transfected with membrane-localized TM-GFP vector (a) GFP-Pin2 (b) for 12 h and treated with 100 ng/ml nocodazole for 16 h or 20 mM lovastatin for 20 h to accumulate cells at mitosis or G1, respectively. Cells were stained with propidium iodide and GFP-positive and -negative cells, separated and their cell cycle pro®les analysed using¯ow cytometry. Percentages and arrows indicate apoptotic cells with the sub-G1 DNA content in total cells examined (Keyomarsi et al., 1991) . Furthermore, sub-G1 apoptotic cells were rather minimal (Figure 5a ). These results indicate that nocodazole and lovastatin do produce the expected cell cycle arrests, which are not signi®cantly aected by GFP. When the cells were transfected with GFP-Pin2, the cell cycle pro®les of the non-transfected cells were similar to those of the control cells (Figure 5b, GFP7) . However, in GFPPin2-positive cells, about 25% of cells were apoptotic, as indicated by the sub-G1 DNA content (Figure 5b , GFP+). This Pin2-induced apoptosis was reduced to 7% after lovastatin treatment, but dramatically increased to 48% after nocodazole treatment (Figure 5b ). These results indicate that Pin2-induced apoptosis is dramatically increased if cells are arrested at mitosis, but decreased if cells are arrested in G1. Taken together, the above results indicate that overexpression of Pin2 induces entry into mitosis and apoptosis.
Overexpression of Pin2 results in activation of capase-3
After establishing that overexpression of Pin2 induces mitotic entry and apoptosis, we asked whether Pin2 activates caspase-3, because during apoptosis caspase-3 is a key executioner that is responsible either partially or totally for the proteolytic cleavage of many essential proteins (Cryns and Yuan, 1998) . Activation of caspase-3 requires proteolytic processing of its inactive form into activated two subunits, p17 and p12 (Nicholson et al., 1995) . Since cleaved caspase-3 antibodies can detect the fragments of activated caspase-3, it is possible to examine the activity of caspase-3 in cells using¯ow cytometry, as shown previously (Belloc et al., 2000) . To examine the eect of overexpression of Pin2 on activation of caspase-3, we transfected cells either with GFP-Pin2 or membrane targeted TM-GFP for 30 h. Cells were stained with the cleaved caspase-3 antibodies and immunoreactivity of GFP-positive and -negative cells was determined bȳ ow cytometry. As shown in Figure 6a , the¯uores-cence intensity of cleaved caspase-3 was signi®cantly increased in cells expressing GFP-Pin2, as compared with that of GFP-negative cells in the same transfection population. In contrast, the¯uorescence intensity of cleaved caspase-3 showed little dierence between TM-GFP-positive and -negative cells. These results indicate that caspase-3 is speci®cally activated in GFPPin2-transfected cells. To examine the signi®cance of the capase-3 activation, we used the caspase-3 inhibitor DEVD-CHO. As shown in Figure 6b , the caspase-3 inhibitor signi®cantly suppressed the ability of Pin2 to induce apoptosis. These results indicate that Pin2 is able to activate caspase-3 and that caspase-3 is a downstream mediator of Pin2-induced apoptosis.
Expression of Pin2/TRF1 is down-regulated in human breast cancer samples
It has been previously shown that overexpression of TRF1 induces telomere shortening (van Steensel and de Lange, 1997). We show that overexpression of Pin2 or TRF1 induces apoptosis. These results led us to suspect that expression of Pin2/TRF1 may be reduced in cancer, where telomeres have to be maintained and apoptosis is often inhibited. To examine this possi- Figure 6 Overexpression of Pin2 leads activation of capase-3 and inhibition of capase-3 suppresses Pin2-induced apoptosis. (a) After 28 h of transfection with expression construct encoding GFP-Pin2 or the membrane targeted GFP (TM-GFP), HeLa cells were ®xed and immunostained with cleaved caspase-3 antibodies and GFP-positive and -negative cells were sorted out and their immunoreactivity was determined by¯ow cytometry. Note, since regular GFP is leaked from cells after ethanol ®xation, TM-GFP was instead used as a control. (b) Cells were pre-incubated with 10 mM of Ac-DEVD-CHO and then transfected with GFP-Pin2 or control GFP. Thirty hours later, cells were ®xed and stained with DAPI, followed by determining percentage of apoptotic cells in total GFP-positive cells Oncogene Apoptosis induced by telomeric protein Pin2/TRF1 S Kishi et al bility, we compared protein levels of Pin2/TRF1 in normal human breast and breast cancer tissues using immunohistochemistry and immunoblotting with anity-puri®ed anti-Pin2/TRF1 antibodies. Pin2/TRF1 was readily detected in ductal epithelial cells, connective tissue and blood vessels in normal breast tissues (Figure 7a) . Furthermore, Pin2/TRF1 staining was primarily in the nucleus (Figure 7a ), as shown previously van Steensel and de Lange, 1997) . However, in®ltrating carcinoma cells displayed much weaker staining with the Pin2/TRF1 antibodies (Figure 7b ). To ensure that these signals indeed represent Pin2/TRF1, the Pin2/TRF1-speci®c antibodies were depleted using GST-Pin2 beads prior to immunostaining. The Pin2/TRF1-depleted antibodies showed no immunoreactivity (data not shown), con®rming the speci®city of the antibodies, as described .
To con®rm the immunostaining results, fresh normal or tumor breast tissues were ground in liquid nitrogen and lysates were directly subjected to immunoblotting analysis, followed by semi-quanti®cation of protein levels using ImageQuant, as described (Lu et al., 1999a) . As an internal control, we used actin, with the Pin2/TRF1 level in each sample being expressed as a ratio between Pin2/TRF1 and actin. Out of 10 normal and 51 primary human breast cancer tissues examined, we observed that levels of Pin2/TRF1 protein in all neoplastic breast tissues were signi®cantly lower that those present in normal control tissues (Figure 7c , Table 3 ). Together, both immunostaining and immunoblotting analyses indicate that expression of PIN2/TRF1 is signi®cantly down-regulated in most breast cancer samples examined.
Discussion
We have demonstrated that up-regulation of Pin2 function results in mitotic entry and then apoptosis. Interestingly, this phenotype depends on the concentration of unbound Pin2 and on telomere length in the cells. Furthermore, overexpression of Pin2 leads to activation of caspase-3 and inhibition of caspase-3 signi®cantly suppresses the ability of Pin2 to induce apoptosis. These results indicate that overexpression of Pin2 speci®cally induces mitotic entry and apoptosis Comparison of Pin2/TRF1 levels in selected normal and cancerous human breast tissues. Breast tissues obtained from three normal and six breast cancer patients were powderized and the same amounts of total protein were directly separated on SDS-containing gels and transferred to membranes. The membranes were cut into two pieces and subjected to immunoblotting analysis using antibodies against to Pin2/TRF1 and actin, respectively The patient cohort included 47 invasive breast carcinoma and four ductal carcinoma in situ. Levels of Pin2/TRF1 in tissues were determined by immunoblotting analysis and semi-quanti®ed using ImageQuant software, with the results being expressed as a ratio between Pin2/TRF1 and actin in each tissue. The signi®cance of the dierences in Pin2/TRF1 levels between normal controls and tumors was analysed using the Kruskall ± Wallis test likely via a mechanism that is related to telomere dysfunction. Finally, we found that levels of Pin2/ TRF1 are signi®cantly reduced in human breast cancer tissues, as compared with those in the normal control. Together with that down-regulation of Pin2/TRF1 allows cells to maintain long telomeres, these results suggest that down-regulation of Pin2/TRF1 may be important for the growth of cancer cells. Several results support that the eects of exogenously expressed Pin2 are speci®c and related to telomeres shortening. First, Pin2-induced apoptosis depends on the concentration of unbound Pin2, which is likely to be higher in cells with short telomeres. Second, Pin2 induces apoptosis only in cells containing short telomeres, but not in cells containing long telomeres, similar to apoptosis induced by inhibition of telomerase (Hahn et al., 1999; Herbert et al., 1999; Zhang et al., 1999) . Third, up-regulation of Pin2 leads to activation of caspase-3, a key executioner of apoptosis, that is responsible either partially or totally for the proteolytic cleavage of many essential proteins during apoptosis (Cryns and Yuan, 1998) . Fourth, inhibition of caspase-3 suppresses the ability of Pin2 to induce apoptosis, indicating that activation of caspase-3 plays an important role during Pin2-induced apoptosis. These results argue that the ratio of`free' and`bound' Pin2 is crucial for cells, and increases as telomeres shorten, eventually leading to apoptotic cell death by mitotic catastrophe.
The ®ndings that Pin2/TRF1 induces entry into mitosis and apoptosis are consistent with previous reports. Deletion of telomeres also induces mitotic arrest and apoptosis in Drosophila eyes in vivo (Ahmad and Golic, 1999) . Furthermore, apoptosis is also triggered by inhibiting telomerase via expression of antisense nucleotide or dominant-negative mutants (Fu et al., 1999; Hahn et al., 1999; Herbert et al., 1999; Kondo et al., 1998a,b,c; Lee et al., 1998; Zhang et al., 1999) and inhibition of the telomeric protein TRF2 (Karlseder et al., 1999) . These results consistently show that modulating telomere length can aect mitosis and lead to apoptosis. Furthermore, we have previously shown that the expression level of Pin2/TRF1 is cell cycle-dependent . Pin2/TRF1 is signi®cantly increased when cells reach late G2 and M phase of the cell cycle, followed by degradation before cells exit from mitosis. Together with the ®ndings that Pin2 contains a D-like motif similar to the destruction box present in many mitotic proteins, we have previously proposed that degradation of Pin2/ TRF1 may be required for cells to exit from mitosis . Our current results, showing that overexpression of Pin2 leads to mitotic entry followed by apoptosis, further support the idea that the function of Pin2/TRF1 is tightly regulated during mitosis.
Pin2-induced apoptosis depends on telomere length in cells. Whereas Pin2 potently induces apoptosis in cells containing short telomeres, such as HeLa cells, A-T22IJE-T and A431, Pin2 fails to induce apoptosis in cells with long telomeres, such as 293, HT1080 and HeLa1.2.11, a HeLa subclone containing long telomeres, even though the protein is expressed and highly concentrated at long telomeres in these cells. This ®nding that the ability of Pin2 to induce apoptosis depends on telomere length may provide an explanation for why TRF1 has not been shown to induce apoptosis in some cells, including HT1080 cells (Karlseder et al., 1999; van Steensel and de Lange, 1997) . It is also consistent with the recent demonstration that the ability of inhibiting telomerase to induce apoptosis highly depends on the length of telomeres (Zhang et al., 1999) . Expression of dominant-negative telomerase mutants induces apoptosis only in cells that contain short telomeres, although it does not induce further shortening of telomeres (Zhang et al., 1999) . Similarly, expression of Pin2 in those cells containing short telomeres does not further shorten telomeres (data not shown). Since telomere length is sensed by the concentration of bound telomeric proteins, as shown in the case of Rap1p (Marcand et al., 1997) , a high concentration of bound Pin2/TRF1 in long telomere cells could be a signal that the telomeres are long enough for cells to continue dividing. Conversely, a high concentration of unbound Pin2/TRF1 in short telomere cells could indicate that the telomeres are too short for the cell to divide. This latter possibility is supported by our ®ndings that the point mutant in the DNA-binding domain does not bind to the telomeric DNA but still potently induces apoptosis. Therefore, telomere length and the concentration of unbound Pin2 may be important signals for cell proliferation.
Although modulating the function of telomerase or either telomeric protein Pin2/TRF1 or TRF2 can all lead to apoptosis, the molecular pathways involved seem quite dierent. It has been demonstrated that apoptosis induced by inhibition of TRF2 is ATM-and p53-dependent (Karlseder et al., 1999) . However, p53 is also functionally absent from all of cell lines sensitive to Pin2/TRF1-induced apoptosis in our studies due to the presence of HPV E6 or SV40 T antigen in these cells. Together with ®ndings that Pin2 or TRF1 also potently induced apoptosis in ATM-negative A-T22IJE-T cells, these results indicate that Pin2/TRF1 induced apoptosis is ATM-and p53-independent. Similarly, p53 is also not required for apoptosis observed in telomerase-inhibited cells (Zhang et al., 1999) . Given that both overexpression of Pin2/TRF1 and inhibition of telomerase inhibit telomere elongation (Hahn et al., 1999; Herbert et al., 1999; van Steensel and de Lange, 1997; Zhang et al., 1999) , it is conceivable that Pin2/TRF1 may induce apoptosis via a mechanism similar to that of telomerase inhibition, although the actual signal to activate apoptosis remains to be elucidated. At least two dierent signaling pathways exist in telomere-mediated apoptosis. One is the ATM-and p53-dependent pathway that is activated by inhibition of TRF2 and the other is the ATM-and p53-independent pathway that is activated by inhibition of telomere elongation via up-regulating Pin2/TRF1 or inhibiting telomerase. The ability to pinpoint the induction of apoptosis in these two pathways may provide a powerful tool to investigate Oncogene Apoptosis induced by telomeric protein Pin2/TRF1 S Kishi et al the molecular nature of the apoptotic response to telomere dysfunction.
Although it remains to be determined whether Pin2/ TRF1 is able to induce mitosis and apoptosis under physiological conditions, there are at least two pathological conditions where Pin2/TRF1-induced apoptosis may be important. One condition is the genetic disorder ataxia-telangiectasia caused by ATM mutations. These patients are hypersensitive to irradiation and cells derived from the patients contain short telomeres and display a prominent G2/M checkpoint defect upon irradiation. These ATM-negative cells fail to delay entry into mitosis and instead are prone to enter mitosis and apoptosis after irradiation (Metcalfe et al., 1996; Pandita et al., 1995; Smilenov et al., 1997; Xia et al., 1996) . Signi®cantly, the hypersensitivity to ionizing radiation is correlated with telomere loss (Metcalfe et al., 1996; Pandita et al., 1995; Smilenov et al., 1997; Xia et al., 1996) . Interestingly, we have shown that ATM binds and negatively regulate the function of Pin2/TRF1 presumably via phosphorylation (Kishi et al, a manuscript submitted). More signi®cantly, if the function of endogenous Pin2/ TRF1 in ATM-negative cells is inhibited by stably expressing dominant-negative Pin2, cells are no longer sensitive to irradiation. Following irradiation, the Pin2/ TRF1-inhibited A-T cells do not enter mitosis and apoptosis, but instead delay entry into mitosis, which is a normal DNA damage response for repairing damaged DNA. These results indicate that inhibition of endogenous Pin2/TRF1 function is sucient to prevent DNA damage-induced mitosis and apoptosis, and also suggest that endogenous Pin2/TRF1 in ATMnegative cells is able to induce mitosis and apoptosis, at least upon DNA damage (Kishi et al., manuscript submitted). Another pathological condition where Pin2/TRF1-induced apoptosis may be signi®cant is cancer cells. In contrast to most somatic cells, where telomeres are shortened with each cell division and there is a limited life span, cancer cells have an unlimited cell division potential and have to maintain their telomeres (Greider and Blackburn, 1996; Lundblad, 2000; Zakian, 1995) . To maintain this continuous cell division, the function of Pin2/TRF1 is likely to be down-regulated in these cancer cells since up-regulation of Pin2/TRF1 results in telomere shortening, as shown previously (van Steensel and de Lange, 1997), and induces apoptosis, as shown here. Indeed, we have now found that Pin2/TRF1 is signi®cantly down-regulated in most human breast cancer samples, as con®rmed both by immunostaining and immunoblotting analysis. A recent immunohistochemical study also revealed a similar down-regulation of Pin2/TRF1 in gastrointestinal tumors (Aragona et al., 2000) . Although the relationship between down-regulation of Pin2 and telomere length in tumor cells remains to be addressed, these results suggest that down-regulation of Pin2/ TRF1 may be a general phenomenon in cancer and this down-regulation may allow cancer cells to extend their proliferative potential. Further studies on the role of Pin2/TRF1 in modulating cell proliferation and cell death may help understand the role of telomere maintenance in cellular aging and transformation.
Materials and methods
Transient transfection and apoptosis assays
For detecting apoptosis using b-gal assay, cells were cotransfected with pSV2-lacZ and vector encoding wild-type or mutant Pin2 for 48 ± 60 h by using the Superfect reagents (Qiagen), ®xed with 0.5% glutaraldehyde and stained with Xgal, as described (Kumar et al., 1994; Mayo et al., 1997) . For the TUNEL assay, cells were cotransfected with Pin2 expression construct and the cell surface marker CD20 for 36 h and then stained with anti-CD20 antibody (Pharmingen), as described (Zhu et al., 1993) . The stained cells were subjected to TUNEL staining and analysed by¯ow cytometry, as described (Douglas et al., 1998; Gavrieli et al., 1992) . To directly observe the morphology of Pin2 expressing cells, Pin2 and its various mutants were expressed as C-terminal fusion proteins with GFP in cells (Clontech). Respective vectors were used in all transfections as controls. Transfected living cells were monitored over time and ®xed at various time points. The indexes of interphase, mitotic and apoptotic cells were determined after staining the cells with the DNA-binding dye DAPI or the mitosis-speci®c monoclonal antibody MPM-2, as described (Lu and Hunter, 1995; Shen et al., 1997) . The apoptosis rate was determined by counting about 300 ± 400 GFP-positive cells.
Analysis of telomere restriction fragment length
Telomere restriction fragment length was determined, as described previously (van Steensel and de Lange, 1997) . In brief, genomic DNA was isolated from the cultured cells using QIAamp Tissue Kit (QIAGEN), and digested with HinfI and RSAI (New England Bio Labs) to generate the telomere restriction enzyme fragments. Ten mg of genomic DNA was separated on a 0.7% agarose gel. This gel was hybridized directly to a 32 P-labeled telomere probe, which was made with (AATCCC) primer using pSP73 Sty11 plasmid as a template in Klenow fragment.
Cell cycle analysis
To enrich cells in G1, cells were treated with 20 mM lovastatin for 20 h, as described (Jakobisiak et al., 1991; Keyomarsi et al., 1991) . To block cells at mitosis, cells were incubated 100 ng/ml nocodazole for 16 h. For cell cycle analysis, cells were harvested by trypsinization, re-suspended in DMEM supplemented with 10% serum, washed in PBS, and then ®xed in 70% ethanol. After washing cells once with PBS containing 1% BSA, DNA was stained with propidium iodide (10 mg/ml) containing 250 mg/ml of ribonuclease A, followed by¯ow cytometry analysis (Becton-Dickinson), as described (Lu and Hunter, 1995) .
Flow cytometric analysis of caspase-3 activation and treatment of caspase-3 inhibitor
After 28 h of transfection with GFP-Pin2 or TM-GFP expression construct, HeLa cells were ®xed and then immunostained with cleaved caspase-3 antibody (Cell Signaling Technology), followed by Rhodamine-conjugated antirabbit secondary antibodies, as described (Belloc et al., 2000) .
The stained cells were analysed by¯ow cytometry for the detection of caspase-3 activation. To inhibit caspase-3, 10 mM of Ac-Asp-Glu-Val-Asp-CHO (Ac-DEVD-CHO) was added to cells before transfection.
Expression of Pin2/TRF1 in human cancer tissues
Fifty-one cancerous and 10 normal breast tissue specimen were randomly selected. Tissue from the core of the tumor had been snap frozen in liquid nitrogen and powderized using a Microdismembrator (Braun). About 10 mg of the powderized tissues were re-suspended in 100 ml of SDS sample buer. Immunoblotting analysis with anti-Pin2/TRF1 and anti-actin antibodies was performed as described . Levels of Pin2/TRF1 were semi-quanti®ed using Imagequant and the signi®cance of the dierences in Pin2/ TRF1 levels between normal and cancer tissues was analysed, as described (Lu et al., 1999a) . To detect the localization of Pin2/TRF1 in human tissues, 50 mm sections were cut from breast cancer tissues, and then microwaved in an antigen retrieval buer (Biogenex), as described by the manufacturer.
Endogenous peroxidase activity was blocked with H 2 O 2 , the sections were incubated with anti-Pin2/TRF1 antibodies that had been puri®ed using GST-Pin2 glutathione beads , and visualized by the immunoperoxidase staining protocol, as described (Lu et al., 1999a) .
